4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-058329
Chief Operating Officer sold 1,616 shares at $10.72 ($17,324)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGH SUSANNA GATTI Chief Operating Officer | 2023-12-11 | Sale | −1,616 | $10.72 | $17,324 | 187,882 | D |
| Open-market sales · 1,616 sh · avg $10.72 · $17,324 | |||||||
Loading xslF345X05/doc4.xml…